Regulatory issues in Europe

被引：8

作者：

Barbui, C ^{[1
]}

Guaiana, G ^{[1
]}

Garatini, S ^{[1
]}

机构：

[1] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy

来源：

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2001年 / 21卷 / 06期

关键词：

D O I：

10.1097/00004714-200112000-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：545 / 548

页数：4

共 13 条

[1] Does placebo help establish equivalence in trials of new antidepressants? [J].

Barbui, C ;

Violante, A ;

Garattini, S .

EUROPEAN PSYCHIATRY, 2000, 15 (04) :268-273

[2] Forty years of antidepressant drug trials [J].

Barbui, C ;

Hotopf, M .

ACTA PSYCHIATRICA SCANDINAVICA, 2001, 104 (02) :92-95

[3] Clinical trials of new antipsychotics: a critical appraisal [J].

Barbui, C ;

Garattini, S .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (02) :133-137

[4]

Enserink M, 2000, SCIENCE, V288, P416

[5] Policing the European pharmaceutical market's priorities [J].

Garattini, S ;

Bertele', V .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (05) :441-443

[6] Adjusting Europe's drug regulation to public health needs [J].

Garattini, S ;

Bertele, V .

LANCET, 2001, 358 (9275) :64-67

[7] Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis [J].

Geddes, J ;

Freemantle, N ;

Harrison, P ;

Bebbington, P .

BRITISH MEDICAL JOURNAL, 2000, 321 (7273) :1371-1376

[8] Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia [J].

Glick, ID ;

Suppes, T ;

DeBattista, C ;

Hu, RJ ;

Marder, S .

ANNALS OF INTERNAL MEDICINE, 2001, 134 (01) :47-60

[9] Putting trials on trial - the costs and consequences of small trials in depression: a systematic review of methodology [J].

Hotopf, M ;

Lewis, G ;

Normand, C .

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1997, 51 (04) :354-358

[10] Trials to assess equivalence: The importance of rigorous methods [J].

Jones, E ;

Jarvis, P ;

Lewis, JA ;

Ebbutt, AF .

BMJ-BRITISH MEDICAL JOURNAL, 1996, 313 (7048) :36-39

← 1 2 →